trial · primary record
Stellate Ganglion Block Injection with 10 mL 0.5% Bupivacaine
Atrial Fibrillation
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 60 |
| Primary completion | 2027-11 |
| Primary endpoint | Success of treatment |
| Registry ID | NCT07893275 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:16.633Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07893275
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.